OpenURL Connection Search

Select item for more details and to access through your institution.

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting.
Published in:
Cancers, 2023, v. 15, n. 5, p. 1374, doi. 10.3390/cancers15051374
By:
- Bos, Manouk K.;
- Verhoeff, Sarah R.;
- Oosting, Sjoukje F.;
- Menke-van der Houven van Oordt, Willemien C.;
- Boers, Ruben G.;
- Boers, Joachim B.;
- Gribnau, Joost;
- Martens, John W. M.;
- Sleijfer, Stefan;
- van Herpen, Carla M. L.;
- Wilting, Saskia M.
Publication type:
Article
89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1944, doi. 10.2967/jnumed.121.263470
By:
- Verhoeff, Sarah R.;
- van de Donk, Pim P.;
- Aarntzen, Erik H. J. G.;
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- Miedema, Iris H. C.;
- Voortman, Jens;
- Menke-van der Houven van Oordt, Willemien C.;
- Boellaard, Ronald;
- Vriens, Dennis;
- Slingerland, Marije;
- Hermsen, Rick;
- van Engen-van Grunsven, Ilse;
- Heskamp, Sandra;
- van Herpen, Carla M. L.
Publication type:
Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262622
By:
- Westdorp, Harm;
- Verhoeff, Sarah R.;
- Gotthardt, Martin;
- van Herpen, Carla M. L.;
- van den Heuvel, Michel M.;
- Heskamp, Sandra;
- Aarntzen, Erik H. J. G.
Publication type:
Article
Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
By:
- Verhoeff, Sarah R.;
- van de Donk, Pim P.;
- Aarntzen, Erik H. J. G.;
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- Miedema, Iris H. C.;
- Voortman, Jens;
- Menke-van der Houven van Oord, Willemien C.;
- Boellaard, Ronald;
- Vriens, Dennis;
- Slingerland, Marije;
- Hermsen, Rick;
- Engen-van Grunsven, Ilse van;
- Heskamp, Sandra;
- van Herpen, Carla M. L.
Publication type:
Article
89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
By:
- Verhoeff, Sarah R.;
- van de Donk, Pim P.;
- Aarntzen, Erik H. J. G.;
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- Miedema, Iris H. C.;
- Voortman, Jens;
- Menke-van der Houven van Oordt, Willemien C.;
- Boellaard, Ronald;
- Vriens, Dennis;
- Slingerland, Marije;
- Hermsen, Rick;
- Engen-van Grunsven, Ilse van;
- Heskamp, Sandra;
- van Herpen, Carla M. L.
Publication type:
Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 114, doi. 10.2967/jnumed.121.262622
By:
- Westdorp, Harm;
- Verhoeff, Sarah R.;
- Gotthardt, Martin;
- van Herpen, Carla M. L.;
- van den Heuvel, Michel M.;
- Heskamp, Sandra;
- Aarntzen, Erik H. J. G.
Publication type:
Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 114, doi. 10.2967/jnumed.121.262622
By:
- Westdorp, Harm;
- Verhoeff, Sarah R.;
- Gotthardt, Martin;
- van Herpen, Carla M. L.;
- van den Heuvel, Michel M.;
- Heskamp, Sandra;
- Aarntzen, Erik H. J. G.
Publication type:
Article
89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263470
By:
- Verhoeff, Sarah R.;
- van de Donk, Pim P.;
- Aarntzen, Erik H. J. G.;
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- Miedema, Iris H. C.;
- Voortman, Jens;
- Menke-van der Houven van Oordt, Willemien C.;
- Boellaard, Ronald;
- Vriens, Dennis;
- Slingerland, Marije;
- Hermsen, Rick;
- van Engen-van Grunsven, Ilse;
- Heskamp, Sandra;
- van Herpen, Carla M. L.
Publication type:
Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262622
By:
- Westdorp, Harm;
- Verhoeff, Sarah R.;
- Gotthardt, Martin;
- van Herpen, Carla M. L.;
- van den Heuvel, Michel M.;
- Heskamp, Sandra;
- Aarntzen, Erik H. J. G.
Publication type:
Article
89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263470
By:
- Verhoeff, Sarah R.;
- van de Donk, Pim P.;
- Aarntzen, Erik H. J. G.;
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- Miedema, Iris H. C.;
- Voortman, Jens;
- van Oordt, Willemien C. Menke-van der Houven;
- Boellaard, Ronald;
- Vriens, Dennis;
- Slingerland, Marije;
- Hermsen, Rick;
- Grunsven, Ilse van Engen-van;
- Heskamp, Sandra;
- van Herpen, Carla M. L.
Publication type:
Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262622
By:
- Westdorp, Harm;
- Verhoeff, Sarah R.;
- Gotthardt, Martin;
- van Herpen, Carla M. L.;
- van den Heuvel, Michel M.;
- Heskamp, Sandra;
- Aarntzen, Erik H. J. G.
Publication type:
Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262622
By:
- Westdorp, Harm;
- Verhoeff, Sarah R.;
- Gotthardt, Martin;
- van Herpen, Carla M. L.;
- van den Heuvel, Michel M.;
- Heskamp, Sandra;
- Aarntzen, Erik H. J. G.
Publication type:
Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262622
By:
- Westdorp, Harm;
- Verhoeff, Sarah R.;
- Gotthardt, Martin;
- van Herpen, Carla M. L.;
- van den Heuvel, Michel M.;
- Heskamp, Sandra;
- Aarntzen, Erik H. J. G.
Publication type:
Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262622
By:
- Westdorp, Harm;
- Verhoeff, Sarah R.;
- Gotthardt, Martin;
- van Herpen, Carla M. L.;
- van den Heuvel, Michel M.;
- Heskamp, Sandra;
- Aarntzen, Erik H. J. G.
Publication type:
Article
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1931, doi. 10.1007/s00259-019-04358-9
By:
- Verhoeff, Sarah R.;
- van Es, Suzanne C.;
- Boon, Eline;
- van Helden, Erik;
- Angus, Lindsay;
- Elias, Sjoerd G.;
- Oosting, Sjoukje F.;
- Aarntzen, Erik H.;
- Brouwers, Adrienne H.;
- Kwee, Thomas C.;
- Heskamp, Sandra;
- Hoekstra, Otto S.;
- Verheul, Henk;
- van der Veldt, Astrid A. M.;
- de Vries, Elisabeth G. E.;
- Boerman, Otto C.;
- van der Graaf, Winette T. A.;
- Oyen, Wim J. G.;
- van Herpen, Carla M. L.
Publication type:
Article

Found: 15

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting.

<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

Lesion detection by [<sup>89</sup>Zr]Zr-DFO-girentuximab and [<sup>18</sup>F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.